AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ALLR · NASDAQ · Biotechnology

Allarity Therapeutics (ALLR)

Develops stenoparib with DRP®-guided patient selection for advanced recurrent ovarian cancer.

$1.41

Pre-market−0.01 (−0.70%)

At close$1.42(0.00%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

	Insiders6 holders · as of May 14, 2026	8.22%	1.31M shares
	Otherremainder	91.78%	14.60M shares

15.91M company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Thomas JensenInsiderofficer: CEO	3.75%	596,734	Form 4filed May 14, 2026 ↗
Jeremy R. GraffInsiderofficer: See Remarks	2.40%	381,644	Form 4filed Apr 30, 2026 ↗
Jeffrey S. ErvinInsiderofficer: CFO	0.94%	150,000	Form 4filed Apr 30, 2026 ↗
Alexander EpshinskyInsiderofficer: CFO	0.53%	85,051	Form 4filed Jan 24, 2025 ↗
Gerald W. McLaughlinInsiderdirector	0.44%	70,000	Form 4filed May 7, 2026 ↗
Jesper HoeilandInsiderdirector	0.16%	25,000	Form 4filed May 11, 2026 ↗
3i, LPStrategic	—9.98% of class, as filed	—	13Gfiled Mar 2, 2023 ↗
Forsakringsaktiebolaget Avanza PensionInsider	—7.00% of class, as filed	—	13G/Afiled Jan 20, 2022 ↗
Intracoastal Capital LLCStrategic	—4.99% of class, as filed	—	13Gfiled Jul 14, 2023 ↗
Page 3 of 8 PagesInsider	—14.70% of class, as filed	—	13Gfiled Aug 29, 2024 ↗
Leon Sass¹Insider10 percent owner	0.00%	1	Form 4filed Dec 22, 2021 ↗
Steen Knudsen¹Insiderofficer: Chief Scientific Officer	0.00%	0	Form 4filed Dec 22, 2021 ↗
Duncan Moore¹Insiderdirector	0.00%	0	Form 4filed Dec 22, 2021 ↗
Marie Foegh¹Insiderofficer: Chief Medical Officer	0.00%	0	Form 4filed Dec 22, 2021 ↗
Soren Gade Jensen¹Insiderdirector	0.00%	0	Form 4filed Dec 22, 2021 ↗

Last filed Dec 22, 2021; leaving the company requires no filing. Not in the bar.

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.